These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


137 related items for PubMed ID: 25130540

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. H5 N-terminal β sheet promotes oligomerization of H7-HA1 that induces better antibody affinity maturation and enhanced protection against H7N7 and H7N9 viruses compared to inactivated influenza vaccine.
    Khurana S, Coyle EM, Verma S, King LR, Manischewitz J, Crevar CJ, Carter DM, Ross TM, Golding H.
    Vaccine; 2014 Nov 12; 32(48):6421-32. PubMed ID: 25284811
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Evaluation of avian influenza virus isolated from ducks as a potential live vaccine candidate against novel H7N9 viruses.
    Jiang WM, Wang SC, Liu HL, Yu JM, Du X, Hou GY, Li JP, Liu S, Wang KC, Zhuang QY, Liu XM, Chen JM.
    Vaccine; 2014 Nov 12; 32(48):6433-9. PubMed ID: 25285880
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Induction of neutralizing antibodies to influenza A virus H7N9 by inactivated whole virus in mice and nonhuman primates.
    Pan W, Han L, Dong Z, Niu X, Li Z, Bao L, Li C, Luo Q, Yang Z, Li X, Huang J, Feng L, Qin C, Zhong N, Chen L.
    Antiviral Res; 2014 Jul 12; 107():1-5. PubMed ID: 24746458
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Protective efficacy of a bivalent inactivated reassortant H1N1 influenza virus vaccine against European avian-like and classical swine influenza H1N1 viruses in mice.
    Ruan BY, Yao Y, Wang SY, Gong XQ, Liu XM, Wang Q, Yu LX, Zhu SQ, Wang J, Shan TL, Zhou YJ, Tong W, Zheng H, Li GX, Gao F, Kong N, Yu H, Tong GZ.
    Vet Microbiol; 2020 Jul 12; 246():108724. PubMed ID: 32605742
    [Abstract] [Full Text] [Related]

  • 15. Amino Acid Substitutions Improve the Immunogenicity of H7N7HA Protein and Protect Mice against Lethal H7N7 Viral Challenge.
    Kumar SR, Prabakaran M, Ashok Raj KV, He F, Kwang J.
    PLoS One; 2015 Jul 12; 10(6):e0128940. PubMed ID: 26030920
    [Abstract] [Full Text] [Related]

  • 16. A highly immunogenic vaccine against A/H7N9 influenza virus.
    Cao W, Liepkalns JS, Hassan AO, Kamal RP, Hofstetter AR, Amoah S, Kim JH, Reber AJ, Stevens J, Katz JM, Gangappa S, York IA, Mittal SK, Sambhara S.
    Vaccine; 2016 Feb 03; 34(6):744-9. PubMed ID: 26765287
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Protective immunity against influenza H5N1 virus challenge in mice by intranasal co-administration of baculovirus surface-displayed HA and recombinant CTB as an adjuvant.
    Prabakaran M, Velumani S, He F, Karuppannan AK, Geng GY, Yin LK, Kwang J.
    Virology; 2008 Oct 25; 380(2):412-20. PubMed ID: 18786689
    [Abstract] [Full Text] [Related]

  • 19. Protective efficacy of an inactivated chimeric H7/H5 avian influenza vaccine against highly pathogenic avian influenza H7N9 and clade 2.3.4.4 H5 viruses.
    Peng C, Hou G, Li J, Wang S, Wang Y, Cheng S, Yu X, Jin J, Jiang W.
    Vet Microbiol; 2018 Sep 25; 223():21-26. PubMed ID: 30173747
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.